Shenzhen Weiguang Biological Products Co Ltd - Asset Resilience Ratio

Latest as of June 2024: 5.52%

Shenzhen Weiguang Biological Products Co Ltd (002880) has an Asset Resilience Ratio of 5.52% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥169.93 Million

≈ $24.87 Million USD Cash + Short-term Investments

Total Assets

CN¥3.08 Billion

≈ $450.47 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2020–2024)

This chart shows how Shenzhen Weiguang Biological Products Co Ltd's Asset Resilience Ratio has changed over time. Check strategic asset allocation of Shenzhen Weiguang Biological Products Co to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Shenzhen Weiguang Biological Products Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Shenzhen Weiguang Biological Products Co worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥169.93 Million	5.52%
Total Liquid Assets	CN¥169.93 Million	5.52%

Asset Resilience Insights

Limited Liquidity: Shenzhen Weiguang Biological Products Co Ltd maintains only 5.52% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Shenzhen Weiguang Biological Products Co Ltd Industry Peers by Asset Resilience Ratio

Compare Shenzhen Weiguang Biological Products Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Shanghai Allist Pharmaceuticals Co. Ltd. A SHG:688578	Biotechnology	21.11%
Tubize-Fin BR:TUB	Biotechnology	0.05%
Sk Biopharmaceuticals Co Ltd KO:326030	Biotechnology	0.14%
Tango Therapeutics Inc NASDAQ:TNGX	Biotechnology	57.90%
TELIX Pharmaceuticals Ltd AU:TLX	Biotechnology	32.29%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
Hangzhou Biotest Biotech Co Ltd SHG:688767	Biotechnology	0.56%
Theravance Biopharma Inc F:0TB	Biotechnology	37.29%

Annual Asset Resilience Ratio for Shenzhen Weiguang Biological Products Co Ltd (2020–2024)

The table below shows the annual Asset Resilience Ratio data for Shenzhen Weiguang Biological Products Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	4.65%	CN¥153.32 Million ≈ $22.43 Million	CN¥3.30 Billion ≈ $482.52 Million	+27.52pp
2023-12-31	-22.87%	CN¥-658.04 Million ≈ $-96.29 Million	CN¥2.88 Billion ≈ $420.96 Million	-15.75pp
2022-12-31	-7.12%	CN¥-183.51 Million ≈ $-26.85 Million	CN¥2.58 Billion ≈ $376.91 Million	-5.95pp
2021-12-31	-1.17%	CN¥-23.53 Million ≈ $-3.44 Million	CN¥2.00 Billion ≈ $293.18 Million	-0.94pp
2020-12-31	-0.23%	CN¥-4.25 Million ≈ $-621.91K	CN¥1.84 Billion ≈ $268.69 Million	--

pp = percentage points

About Shenzhen Weiguang Biological Products Co Ltd

SHE:002880 China Biotechnology

Market Cap

$672.72 Million

CN¥4.60 Billion CNY

Market Cap Rank

#10671 Global

#2866 in China

Share Price

CN¥20.27

Change (1 day)

+0.45%

52-Week Range

CN¥18.80 - CN¥31.04

All Time High

CN¥963796.17